Multiple myeloma trials in Switzerland
13 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Where
- Bern, Sankt Gallen
- Age
- 18 years and over
- People
- 1,590 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05552222 · EU 2023-503442-30-00 - Phase 3Taking peopleA Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
- Where
- Bern, Sankt Gallen
- Age
- 18 years and over
- People
- 440 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06615479 · EU 2024-515279-37-00 - Phase 3Taking peopleA Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
- Where
- Bern, Winterthur
- Age
- 18 years and over
- People
- 1,060 worldwide
- Run by
- Pfizer
See details and how to joinNCT05623020 · EU 2024-514139-50-00 - Phase 3Taking peoplePhase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
- Where
- Basel, Bern, Sankt Gallen
- Age
- 18 years and over
- People
- 1,594 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to joinNCT05243797 · EU 2023-510384-36-00 - Phase 1/2Not yet taking people in SwitzerlandFAPI PET Imaging - An Exploratory Study
- Where
- Baden, Geneva, Genolier, Lucerne, Zurich
- Age
- 18 years and over
- People
- 770
- Run by
- Martin Huellner
See details and how to joinNCT07705074 - No phaseNot yet taking people in SwitzerlandEarly Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging
- Where
- Zurich
- Age
- 18 years and over
- People
- 50
- Run by
- University of Zurich
See details and how to joinNCT07624760 - Phase 3Taking peopleA Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
- Where
- Basel, Sankt Gallen
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to joinNCT06932562 · EU 2024-519827-16-00 - Phase 1/2Taking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Basel, Bern, Zurich
- Age
- 12 years and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - No phaseTaking peopleTransgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Where
- Aarau
- People
- 50 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06357754 - No phaseTaking peoplePragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)
- Where
- Bern, Zurich
- Age
- 65 years and over
- People
- 208
- Run by
- University of Zurich
See details and how to joinNCT07309497 - No phaseTaking peopleEuropean Myeloma Network (EMN) Sample Project
- Where
- Lausanne, Sankt Gallen
- Age
- 18 years and over
- People
- 6,000 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to joinNCT06237803 - Phase 2Taking peopleClinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients
- Where
- Bern
- Age
- 18 years to 75 years
- People
- 120
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT05636787 - Phase 2Taking peoplePRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)
- Where
- Bern
- Age
- 18 years and over
- People
- 100
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT06430736